Biogen Inc (BIIB) Stock Price Today
Aura AI Summary
Key Stats
- $28.34BMarket Cap
- -Volume
- HealthSector
- $216.6352W High
- $122.6852W Low
- -Typical Hold Time
- $30.62BEnterprise Value
- -Div Yield
- -Trading Activity
Track Biogen Inc (BIIB) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Biogen Inc has traded between a low of $122.68 and a high of $216.63, highlighting its annual price range. Buy and sell Biogen Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Biogen Inc
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Most Recent News
Autoimmune therapeutics market to reach $137.85B by 2035, driven by biologics and precision medicine growth
The global autoimmune disease therapeutics market is projected to grow from $80.54 billion in 2025 to $137.85 billion by 2035, at a CAGR of 5.52%. Growth is fueled by rising autoimmune disease prevalence, advances in biologics, JAK inhibitors, monocl...
Ada Water Treatment Plant in West Virginia honored for 25 years of water quality excellence
The Ada Water Treatment Plant in Bluefield, West Virginia, received the 25-year Directors Award from the Partnership for Safe Water for its long-term commitment to providing high-quality drinking water. This recognition highlights the plant's consist...
Low-cost processing could double gallium grades at G50's Golconda project, with gold and silver as co-products.
G50 Corp announced that Phase 2 metallurgical tests at its Golconda project in Arizona show low-cost processing could double gallium grades while also producing gold and silver. This breakthrough reduces risks in gallium extraction, a critical minera...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.